These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3463774)

  • 1. [Antibiotic activities of cefuzoname and the representative cephalosporins against clinically isolated methicillin resistant strains of Staphylococcus].
    Arai T
    Jpn J Antibiot; 1986 May; 39(5):1237-40. PubMed ID: 3463774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
    Uete T; Matsuo K
    Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fundamental and clinical studies on cefuzoname in the pediatric field].
    Toyonaga Y; Sugita M; Kawamura K; Seo K; Takahashi T; Hori M
    Jpn J Antibiot; 1987 Apr; 40(4):843-65. PubMed ID: 3613094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. I. Effect of NaCl.
    Uete T; Matsuo K
    Jpn J Antibiot; 1995 Apr; 48(4):553-62. PubMed ID: 7783318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. II. Effect of inoculum size.
    Uete T; Matsuo K
    Jpn J Antibiot; 1995 Apr; 48(4):563-70. PubMed ID: 7783319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftizoxime (FK 749) in vitro antibacterial activity.
    Husson MO; Courcol R; Izard D; Leclerc H
    Infection; 1984; 12(1):40-5. PubMed ID: 6323320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibility to cefazolin, cefamandole and ceftazidime in Staphylococcus strains].
    Wiktorowicz-Belzyt E; Wojak I; Janicka G
    Med Dosw Mikrobiol; 1997; 49(1-2):35-43. PubMed ID: 9411070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population analysis in strains of Staphylococcus aureus and Staphylococcus epidermidis. II. Cefuroxime and cefotaxime.
    Hansen BG
    Acta Pathol Microbiol Immunol Scand B; 1983 Dec; 91(6):425-9. PubMed ID: 6324530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
    Hara T; Araake M; Tsuruoka T; Watabe H
    Jpn J Antibiot; 2003 Apr; 56(2):142-7. PubMed ID: 12825415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime.
    Yourassowsky E; van der Linden MP; Crokaert F
    Antimicrob Agents Chemother; 1990 Apr; 34(4):505-9. PubMed ID: 2344158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
    Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
    Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility of some bacteria isolated from clinical samples to third-generation cephalosporins].
    Willke A; Tural D
    Mikrobiyol Bul; 1987 Oct; 21(4):279-83. PubMed ID: 3332704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci.
    Menzies RE; Cornere BM; MacCulloch D
    Antimicrob Agents Chemother; 1987 Jan; 31(1):42-5. PubMed ID: 3646002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal disk susceptibility testing of Staphylococcus epidermidis and aureus against penicillinase-resistant semisynthetic penicillins and cephalosporins.
    Wybo I; Pierard D; Lauwers S
    J Chemother; 1989 Jul; 1(4 Suppl):324-5. PubMed ID: 16312422
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of cefotaxime against clinically significant pathogens.
    Nakashio S; Nakamura M
    Drugs; 1988; 35 Suppl 2():14-21. PubMed ID: 3260852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience of cefuzoname in pediatric patients. Fundamental and clinical investigations].
    Kamiya H; Arai S; Kawai K; Ihara T; Sakurai M; Shimizu S; Kodama K; Iwasa T; Inoue M; Kojima M
    Jpn J Antibiot; 1987 Apr; 40(4):867-82. PubMed ID: 3613095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.